MAPT and Alzheimer disease: Thus, different models, such as the triple transgenic (3xTg) one, have been developed to study tauopathies based on genetic alterations in the Tau protein, while triggering receptor expressed on myeloid cells 2 (TREM2) models have been developed to explore the role of microglia in AD pathogenesis.103, 104, 105, 106